COMPANY

GeneToBe Inc.

HQ: Northville, MI source · genetobe.com ↗ · Midwest

Keywords: gene therapy CRISPR

Location: Northville, MI · source · Oct 15, 2026

Profile checked Oct 10, 2026

NIH awards 6

Annual award amounts. Total $3.1M.

Sep 6, 2024 NIH award 1R42DK141338-01 FY2024: $306,779 awarded for that fiscal year; activity R42 (STTR); PI XU, JIE; recipient as written: GENETOBE INC., ANN ARBOR, MI. Novel Selective SGLT-1 Inhibitors for Adjunctive Therapy f source ↗
Jul 30, 2024 NIH award 5UT2AA031151-02 FY2024: $982,659 awarded for that fiscal year; activity UT2 (STTR); PI LIU, WANQING; recipient as written: GENETOBE INC., ANN ARBOR, MI. A Precision Medicine for Alcohol-Associated Liver Dis source ↗
Feb 15, 2024 NIH award 1R41GM153041-01 FY2024: $293,319 awarded for that fiscal year; activity R41 (STTR); PI HOU, ZHONGGANG; recipient as written: GENETOBE INC., ANN ARBOR, MI. Developing novel Type 1 CRISPR tools for gene editi source ↗
Sep 20, 2023 NIH award 1UT2AA031151-01 FY2023: $976,742 awarded for that fiscal year; activity UT2 (STTR); PI LIU, WANQING; recipient as written: GENETOBE INC., ANN ARBOR, MI. A Precision Medicine for Alcohol-Associated Liver Dis source ↗
Aug 31, 2023 NIH award 1R42EY035582-01 FY2023: $289,895 awarded for that fiscal year; activity R42 (STTR); PI YANG, DONGSHAN; recipient as written: GENETOBE INC., ANN ARBOR, MI. Genome Editing Therapy for Usher Syndrome Type 3 source ↗
Jun 7, 2023 NIH award 6R41HL164205-02 FY2022: $246,100 awarded for that fiscal year; activity R41 (STTR); PI XU, JIE; recipient as written: GENETOBE INC., ANN ARBOR, MI. Development of miCas9 mediated gene editing therapies for source ↗